Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Asher Bio develops selective immunotherapy drugs that target specific immune cell types to promote beneficial effects while minimizing toxicity. The company is advancing etakafusp alfa, a cis-targeting IL-2 candidate, for solid tumor treatment and applying its platform to oncology and infectious disease indications.
6 investors
Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease. The company is a clinical-stage biotechnology firm focused on personalized neuron replacement therapies.
6 investors
Augmedics develops augmented reality surgical navigation technology aimed at improving outcomes in spine surgery. Its system gives surgeons AR-based visualization to guide procedures such as screw placement, serving surgeons and hospitals in the medical device market.
6 investors
Avive develops automated external defibrillators (AEDs) and cardiac emergency response systems designed to improve outcomes for sudden cardiac arrest. The company serves communities, first responders, and institutions seeking accessible, affordable life-saving equipment.
6 investors
Avro Life Sciences develops platform technology for novel drug delivery through passive transdermal administration. The company operates in the biotech sector, focusing on dermatological and systemic therapeutics.
6 investors
Axoft is developing soft, tissue-mimicking neural implants and supporting bidirectional electronics that record and stimulate brain activity through a minimally-invasive burr-hole procedure. The company also builds a Brain Foundation Model software to decode and interpret neural signals for brain-computer interface applications.
6 investors
Bayesian Health develops clinical artificial intelligence for real-time patient monitoring and clinical decision support. The company serves healthcare providers and care teams with data-driven tools to improve patient outcomes.
6 investors
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions. The company was founded in 2025 following a strategic combination of atai Life Sciences and Beckley Psytech.
6 investors
Binah.ai develops contactless blood pressure and cardiac monitoring technology using optical remote photoplethysmography (rPPG) and AI-driven computer vision to analyze facial light reflections. The platform measures blood pressure, cardiac workload, pulse pressure, and mean arterial pressure for healthcare applications.
6 investors
Osteoboost is an FDA-cleared, drug-free prescription device that delivers precision vibration therapy to slow bone loss in postmenopausal women with osteopenia. The product targets bone density and strength loss in the spine and hip, backed by clinical trial data.
6 investors
BrainCheck offers a platform for cognitive assessment and care planning, centered on an FDA-registered Class II digital cognitive assessment plus over 30 clinical evaluation tools that integrate into clinical workflows and EHR systems like Epic and athenahealth. It serves neurologists, psychiatrists, primary care providers, and clinical researchers to detect cognitive impairment such as mild cognitive impairment and dementia.
6 investors
Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor. The company serves patients with chronic neurological and related conditions using bioelectronic medicine technology.
6 investors
Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment. The company partners with licensed dentists and orthodontists to provide high-quality orthodontic care.
6 investors
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.
6 investors
Cellineobio develops cell engineering and bioprocess technology platforms. The company serves biotech and pharmaceutical research and manufacturing customers.
6 investors
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
6 investors
Clinikally develops and sells dermatology-backed skin and hair care products for Indian consumers, complemented by online consultations with dermatologists. The company formulates medical-grade products targeting specific skin and hair conditions using high-quality ingredients sourced from Europe and the USA, with efficacy validated through clinical studies.
6 investors
Conceivable builds AURA, a robotic automation platform that automates manual IVF laboratory procedures using physical AI, aiming to increase accessibility and affordability of in-vitro fertilization treatments.
6 investors
Cordance Medical is developing NeuroAccess, a non-invasive medical device that uses low-frequency focused ultrasound and microbubbles to reversibly open the blood-brain barrier at targeted sites, enabling drug delivery and blood-based biomarker measurement. It targets brain diseases including brain cancers, Alzheimer's, Parkinson's, and epilepsy, and its device received the FDA's Breakthrough Device Designation.
6 investors
Correlia Bio develops the PIXI platform, a benchtop automated immunoassay system that uses proprietary microfluidic gel technology to quantify proteins from samples as small as 1 uL. Aimed at pharmaceutical and proteomics researchers, it offers a faster alternative to traditional ELISA for protein measurement in laboratory workflows.
6 investors
DermBiont develops SM-030, a topical drug candidate targeting melasma, a skin pigmentation disorder, by inhibiting PKC-beta to address the underlying cause of hyperpigmentation.
6 investors
eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.
6 investors
Element Biosciences develops biological analysis platforms and DNA sequencing tools for scientists and research institutions. The company serves a global customer base across 40+ countries in the life sciences and genomics industry.
6 investors
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure. The system enables clinicians to remotely optimize heart failure medication and supports patient self-monitoring.
6 investors